<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CRYL1</id>
	<title>CRYL1 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CRYL1"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CRYL1&amp;action=history"/>
	<updated>2026-06-24T23:34:42Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=CRYL1&amp;diff=6273&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH) [CRY]  ==Publications==  {{medline-entry |title=Lipid and Alzheimer&#039;s disease genes...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CRYL1&amp;diff=6273&amp;oldid=prev"/>
		<updated>2021-05-12T15:20:42Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH) [CRY]  ==Publications==  {{medline-entry |title=Lipid and Alzheimer&amp;#039;s disease genes...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH) [CRY]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Lipid and Alzheimer&amp;#039;s disease genes associated with healthy aging and longevity in healthy oldest-old.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28206976&lt;br /&gt;
|abstract=Several studies have found that long-lived individuals do not appear to carry lower numbers of common disease-associated variants than ordinary people; it has been hypothesized that they may instead carry protective variants. An intriguing type of protective variant is buffering variants that protect against variants that have deleterious effects. We genotyped 18 variants in 15 genes related to longevity or healthy aging that had been previously reported as having a gene-gene interaction or buffering effect. We compared a group of 446 healthy oldest-old &amp;#039;Super-Seniors&amp;#039; (individuals 85 or older who have never been diagnosed with cancer, cardiovascular disease, dementia, diabetes or major pulmonary disease) to 421 random population-based midlife controls. Cases and controls were of European ancestry. Association tests of individual SNPs showed that Super-Seniors were less likely than controls to carry an [[APOE]]ε4 allele or a haptoglobin [[HP]]2 allele. Interactions between [[APOE]]/FOXO3, [[APOE]]/[[CRYL1]], and LPA/[[CRYL1]] did not remain significant after multiple testing correction. In a network analysis of the candidate genes, lipid and cholesterol metabolism was a common theme. [[APOE]], [[HP]], and [[CRYL1]] have all been associated with Alzheimer&amp;#039;s Disease, the pathology of which involves lipid and cholesterol pathways. Age-related changes in lipid and cholesterol maintenance, particularly in the brain, may be central to healthy aging and longevity.&lt;br /&gt;
|mesh-terms=* Aged, 80 and over&lt;br /&gt;
* Aging&lt;br /&gt;
* Alzheimer Disease&lt;br /&gt;
* Epistasis, Genetic&lt;br /&gt;
* Female&lt;br /&gt;
* Gene Regulatory Networks&lt;br /&gt;
* Genetic Predisposition to Disease&lt;br /&gt;
* Genotype&lt;br /&gt;
* Humans&lt;br /&gt;
* Lipid Metabolism&lt;br /&gt;
* Longevity&lt;br /&gt;
* Male&lt;br /&gt;
* Polymerase Chain Reaction&lt;br /&gt;
* Polymorphism, Single Nucleotide&lt;br /&gt;
|keywords=* APOE&lt;br /&gt;
* Alzheimer’s disease&lt;br /&gt;
* Gerotarget&lt;br /&gt;
* buffering&lt;br /&gt;
* epistasis&lt;br /&gt;
* healthy aging&lt;br /&gt;
* longevity&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400530&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>